Literature DB >> 21783533

Developing an exposure-dose-response model for the acute neurotoxicity of organic solvents: overview and progress on in vitro models and dosimetry.

Philip J Bushnell1, Timothy J Shafer, Ambuja S Bale, William K Boyes, Jane Ellen Simmons, Christopher Eklund, Trachette L Jackson.   

Abstract

We are developing an exposure-dose-response (EDR) model for volatile organic compounds (VOCs) to predict acute effects of VOCs on nervous system function from exposure data (concentration and duration of inhalation). This model contains both toxicokinetic and toxicodynamic components. One advantage of the EDR model will be its ability to relate in vitro effects of solvents on cellular ion channels (putative targets) to in vivo effects, using a combination of physiologically-based toxicokinetic (PBTK) modeling (to estimate VOC concentrations in the blood and brain) and in vitro studies to clarify the mode of action of the VOCs. Recent work in vitro has focused on quantifying the inhibitory effects of toluene, trichloroethylene (TCE) and perchloroethylene (PERC) on ion channel currents. All three VOCs inhibit current through voltage-sensitive calcium channels (VSCCs) in pheochromocytoma cells; PERC blocked calcium currents and altered the current-voltage relationship at lower concentrations than did toluene or TCE. Recombinant nicotinic acetylcholine receptors (nAChRs), expressed in Xenopus oocytes, were also inhibited by PERC and toluene in a concentration-dependent manner. PERC inhibited α7 receptors more than α4β2 receptors in recombinant human and rat nAChRs. However, human and rat α7 receptors were equally sensitive to PERC and TOL. These in vitro studies will be used to identify an appropriate neuronal receptor system to serve as an index of acute effects of VOCs in vivo. The PBTK model incorporates physiological input parameters derived from radiotelemetered heart rate data from rats performing operant tests of cognitive and motor functions. These studies should improve predictions of target organ concentrations of inhaled VOCs in subjects actively performing behavioral tests over a range of physical activity levels.

Entities:  

Year:  2005        PMID: 21783533     DOI: 10.1016/j.etap.2004.12.026

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  5 in total

1.  Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Appl Pharmacol       Date:  2018-05-29       Impact factor: 4.219

2.  PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-21       Impact factor: 4.219

3.  Editor's Highlight: Genetic Targets of Acute Toluene Inhalation in Drosophila melanogaster.

Authors:  Philip J Bushnell; William O Ward; Tatiana V Morozova; Wendy M Oshiro; Mimi T Lin; Richard S Judson; Susan D Hester; John M McKee; Mark Higuchi
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

4.  Quantitative Characterization of Population-Wide Tissue- and Metabolite-Specific Variability in Perchloroethylene Toxicokinetics in Male Mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Sci       Date:  2021-08-03       Impact factor: 4.849

5.  Development of a direct exposure system for studying the mechanisms of central neurotoxicity caused by volatile organic compounds.

Authors:  Masanari Kanemitsu; Yukiko Fueta; Toru Ishidao; Shuji Aou; Hajime Hori
Journal:  Ind Health       Date:  2015-08-28       Impact factor: 2.179

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.